Altimmune, Inc.ALTNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-8.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-8.3%/yr
vs -21.8%/yr prior
Acceleration
+13.5pp
Accelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 15.42% |
| 2024 | -5.33% |
| 2023 | -21.13% |
| 2022 | 20.01% |
| 2021 | -128.06% |
| 2020 | -257.28% |
| 2019 | -2.27% |
| 2018 | 53.55% |
| 2017 | -110.03% |
| 2016 | 6365.84% |